Sodexo Q3 Fiscal 2025 revenues in line with expectations Issy-les-Moulineaux, July 1, 2025 (7am)Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY) Organic revenue growth of +3.0%Fiscal 2025 expected to land at the lower end of the guidance range: Organic revenue growth between +3% and +4%Underlying operating profit margin improvement between +10 and +20 bps, at constant currencies Q3 FISCAL 2025 REVENUES REVENUES(in million euros)Q3 FY25Q3 FY24 ORGANICGROWTHEXTERNALGROWTHCURRENCYEFFECTTOTALGROWTHNorth America2,8732,904 +1.2%+0.1%-2.4%-1.1%Europe2,1762,096 +3.3%+0.0%+0.5%+3.8%Rest of ...
Sodexo : Chiffre d’affaires du 3e trimestre de l’exercice 2025 en ligne avec les attentes Issy-les-Moulineaux, le 1er juillet 2025 (7h00)Sodexo (Euronext Paris FR 0000121220-OTC : SDXAY) Croissance interne du chiffre d’affaires de +3,0% Exercice 2025 attendu dans le bas de la fourchette des objectifs annuels : Croissance interne du chiffre d'affaires entre +3% et +4%Marge d’exploitation en hausse de +10 à +20 points de base, à taux constants CHIFFRE D’AFFAIRES DU 3e TRIMESTRE DE L’EXERCICE 2025 CHIFFRE D’AFFAIRES(en millions d’euros)T3 2025T3 2024 CROISSANCEINTERNECROISSANCEEXTERNEE...
A director at Novartis AG sold 4,400 shares at 96.069CHF and the significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
ODDO BHF and Commerzbank jointly hosted the Swiss Equities Conference in Interlaken, Switzerland, from 10 to 12 June 2025. The event was attended by 64 companies (out of which 59 are listed, and with BASF one non-Swiss company). Some 125 investors met mostly (85%) C-level management in 440 meetings (one-on-one, one-to-few) and plenary sessions, resulting in some 1,100 interactions. Based on our positive assessments for Q2 & H2 2025 as well as beyond, we would like to highlight Accelleron (poten...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.